| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |